iCAD Presents its Complete Suite of Breast Cancer AI Solutions at the European Congress of Radiology - GlobeNewswire
7/13/2022 12:00:00 AM2 years 9 months ago
by iCAD Inc.
by iCAD Inc.
Compelling clinical evidence shows ProFound AI Risk accurately identified a high-risk group of women with 32 times higher risk of breast cancer than...
NASHUA, N.H., July 13, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that the Com… [+8030 chars]
full article...